Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Reva Medical Inc (OTC: RVALL).

Full DD Report for RVALL

You must become a subscriber to view this report.


Recent News from (OTC: RVALL)

Reva Medical reports Q2 results
Reva Medical ( OTC:RVALL ): Q2 EPS of -$0.13 More news on: Reva Medical Inc, Earnings news and commentary, , Read more ...
Source: SeekingAlpha
Date: August, 07 2018 09:03
Rounds Report: Solid Rallied Aggressively Due To The Clinical Hold Removal For IGNITE DMD
On the other hand, investing is a unique kind of casino - one where you cannot lose in the end, so long as you play only by the rules that put the odds squarely in your favor. - Benjamin Graham Trading Analytics Welcome to the edition of Integrated BioSci Rounds Report for June 19, 2...
Source: SeekingAlpha
Date: June, 21 2018 03:06
REVA Medical (RVALL) Presents At EuroPCR conference 2018 - Slideshow
The following slide deck was published by Reva Medical Inc in conjunction with this Read more ...
Source: SeekingAlpha
Date: May, 25 2018 13:28
Key events next week - healthcare
Noteworthy events during the week of May 20 - 26 for healthcare investors: More news on: uniQure N.V., Roche Holding Ltd ADR, BioMarin Pharmaceutical Inc., Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 18 2018 16:37
Reva Medical (RVALL) Investor Presentation - Slideshow
The following slide deck was published by Reva Medical Inc in conjunction with this Read more ...
Source: SeekingAlpha
Date: May, 17 2018 13:33
Reva Medical reports Q1 results
Reva Medical ( OTC:RVALL ): Q1 EPS of -$0.05 More news on: Reva Medical Inc, Earnings news and commentary, , Read more ...
Source: SeekingAlpha
Date: May, 09 2018 09:05
REVA Medical (RVALL) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
The following slide deck was published by Reva Medical Inc in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 15 2018 14:13
Reva Medical reports Q4 results
Reva Medical ( OTC:RVALL ): Q4 EPS of -$0.10 More news on: Reva Medical Inc, Earnings news and commentary, , Read more ...
Source: SeekingAlpha
Date: March, 07 2018 16:38
REVA Medical (RVALL) Presents At PiperJaffray 29th Annual Healthcare Conference - Slideshow
The following slide deck was published by Reva Medical Inc in conjunction with this Read more ...
Source: SeekingAlpha
Date: November, 28 2017 12:59
Reva Medical reports Q3 results
Reva Medical ( OTC:RVALL ): Q3 EPS of -$0.04 More news on: Reva Medical Inc, Earnings news and commentary, , Read more ...
Source: SeekingAlpha
Date: November, 07 2017 17:29

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-07N/A0.15N/AN/A0
2018-12-060.150.150.150.151,000
2018-12-05N/A0.18N/AN/A0
2018-12-04N/A0.18N/AN/A0
2018-12-03N/A0.18N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-306,5606,560100.0000Short
2018-11-26500500100.0000Short
2018-11-1950,00050,000100.0000Short
2018-10-311,0001,000100.0000Short
2018-10-3014,21514,215100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on RVALL.


About Reva Medical Inc (OTC: RVALL)

Logo for Reva Medical Inc (OTC: RVALL)

Not available

 

Contact Information

 

 

Current Management

  • Regina Groves / CEO, Principal Executive Officer
    • Ms. Groves has over years experience in medical devices, executive leadership, and financial management. Since , Ms. Groves has been employed by Medtronic, Inc. Medtronic . Since , she has served as Vice President and General Manager of the AF Solutions, Cardiac Rhythm and Heart Failure division of Medtronic. Prior to that, she served as Vice President, Quality and Regulatory, Cardiac Rhythm Disease Management CRDM for Medtronic s Cardiac Rhythm Disease Management business from to and served as Vice President and General Manager for Patient Management CRDM at Medtronic from to .
  • Katrina Thompson / CFO
  • Ross Breckenridge /
  • Scott Huennekens /

Current Share Structure

     


    Recent Filings from (OTC: RVALL)

    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: May, 17 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: May, 17 2018
    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: May, 09 2018
    Additional proxy soliciting materials - definitive
    Filing Type: DEFA14AFiling Source: edgar
    Filing Date: April, 05 2018
    Official notification to shareholders of matters to be brought to a vote (Proxy)
    Filing Type: DEF 14AFiling Source: edgar
    Filing Date: April, 05 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: March, 26 2018
    Preliminary proxy statement providing notification matters to be brought to a vote
    Filing Type: PRE 14AFiling Source: edgar
    Filing Date: March, 26 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: March, 13 2018
    Annual report with a comprehensive overview of the company
    Filing Type: 10-KFiling Source: edgar
    Filing Date: March, 07 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: March, 07 2018

     

     


    Daily Technical Chart for (OTC: RVALL)

    Daily Technical Chart for (OTC: RVALL)


    Stay tuned for daily updates and more on (OTC: RVALL)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: RVALL)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in RVALL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of RVALL and does not buy, sell, or trade any shares of RVALL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/